From Wikipedia, the free encyclopedia
 |
|
Artenimol
|
| Systematic (IUPAC) name |
| (3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3,-j)-1,2-benzodioxepin-10-ol |
| Identifiers |
| CAS number |
81496-81-3 |
| ATC code |
P01BE05 |
| PubChem |
179336 |
| Chemical data |
| Formula |
C15H24O5 |
| Mol. mass |
284.348 g/mol |
| Pharmacokinetic data |
| Bioavailability |
? |
| Metabolism |
? |
| Half life |
? |
| Excretion |
? |
| Therapeutic considerations |
| Pregnancy cat. |
?
|
| Legal status |
|
| Routes |
? |
Artenimol is an antimalarial drug. It is a semi-synthetic derivative of artemisinin. Its primary use is as an intermediate in the preparation of experimental artemisinin-derived antimalarial drugs.[1]
[edit] References
